C71T
CANCELLED SECTION 71
15/05/2026
Voltar para busca
Dado oficial do USPTO
INNOPHLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
INNOPHLEX
ST13
US500000079236788Classe
35, 42, 44
Pedido
79236788
Registro
5893636
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
09/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42, 44
Data de depósito
12/01/2018
Data de registro
29/10/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/05/2026
Última transação
09/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
Friedrichsdorf, DE
Examinador
PODESTA, GIDETTE
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PharmaLex GmbH
Representantes
Mark J. Liss Leydig, Voit & Mayer Ltd.
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising servicesbusiness management for otherscompany administration in the nature of business administration services; providing office functions; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy in the context of the retailing and wholesaling of medicines; providing of outsourcing services in the field of business management for companies engaged in the field of medicine authorizationproductionsalesafety and monitoring; regulatory submission managementfiling of documents for authorizing medicines using documentsreports and files required by regulatory authorities; administrative assistance and consultancy in the nature of preparation and filing of applications for pharmaceutical medicine approval with governmental regulatory bodies
Classe 42
Scientific and technological services and research and design relating theretoscientific researchlaboratory research in the field of pharmaceuticals; industrial analysis and research serviceslaboratory research services relating to pharmaceuticalspharmaceutical research services; research and development of new products for others; provision of surveysmedical research surveys; software development servicesdevelopment of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; research in relation to scientific work; preparation of scientific analysis and assessments; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology advisoryconsultancy and information services for the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticals being pharmaceutical product evaluation; analysis and evaluation of product design; analysis and evaluation of product development; quality control testing for others; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for certification purposes; assistance and consultancy in the nature of pharmaceutical research in the field of medicine safety and monitoring; pharmaceutical drug development consultancy in the field of medicine safety
Classe 44
Providing pharmaceutical and medical assistance and consultancy during an initial application process of marketing authorization or product approval for pharmaceutical companies; provision of medical and pharmaceutical advice and expertise for pharmaceutical companies; providing information relating to the preparation and dispensing of medications; provision of pharmaceutical information; provision of information relating to medicine; consultancy and information services provided via the internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; advisory services relating to pharmaceuticals; medical servicesmedical diagnostic services; medical servicesmedical diagnostic services and pharmaceutical advisory services and consultancy in the field of medicine safety
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/02/2020
FIMP
FINAL DISPOSITION PROCESSED
19/02/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
29/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/08/2019
PUBO
PUBLISHED FOR OPPOSITION
13/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
09/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/07/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/07/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/01/2019
GNFR
FINAL REFUSAL E-MAILED
15/01/2019
CNFR
FINAL REFUSAL WRITTEN
15/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/12/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/12/2018
ALIE
ASSIGNED TO LIE
22/12/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2018
RFNT
REFUSAL PROCESSED BY IB
01/09/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/08/2018
RFRR
REFUSAL PROCESSED BY MPU
13/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/07/2018
CNRT
NON-FINAL ACTION WRITTEN
30/07/2018
MAFR
APPLICATION FILING RECEIPT MAILED
27/07/2018
DOCK
ASSIGNED TO EXAMINER
23/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/07/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INNOPHLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.